November 22, 2022
Japan’s oncology market is projected to reach 1,991.3 billion yen in 2030, up 26% compared to 2021, with growth in immune checkpoint inhibitors expected to more than offset impacts from potential re-pricing, according to market research firm Fuji Keizai. The...read more